A phase II study of cellular adoptive immunotherapy with donor-derived CMV-specific T-cell clones as prophylaxis for CMV disease in allogeneic HCT recipients

被引：0
|
作者：
Boeckh, M. [1 ]
Manley, T. [1 ]
Greenberg, P. [1 ]
Kirby, K. [1 ]
Riddell, S. [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源：
BONE MARROW TRANSPLANTATION | 2007年 / 39卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [31] Analysis of CMV-specific T-cell reconstitution following BMT to identify patients risk of late onset CMV disease
    Hebart, H
    Krause, H
    Wagner, I
    Muller, CA
    Jahn, G
    Einsele, H
    BLOOD, 1995, 86 (10) : 852 - 852
  • [32] Comparison of Transplant Donor and Third-Party Donor Derived CMV-Specific T Cells for CMV Infection after Allogenic Stem Cell Transplantation
    Pei, Xuying
    Liu, Xuefei
    Zhao, Xiang-Yu
    Chang, Yingjun
    Lv, Meng
    Mo, Xiaodong
    Sun, Yuqian
    Xu, Lanping
    Wang, Yu
    Zhang, Xiaohui
    Huang, Xiaojun
    BLOOD, 2021, 138
  • [33] Transduction of CMV-Specific T Cells with Anti-HIV CAR Vectors and Adoptive T Cell Immunotherapy in NHP Model
    Braun, Stephen E.
    Wu, Chengxiang
    Yu, Shan
    Lo, Agnes
    Li, Hai
    Sahu, Gautam
    Marx, Preston
    von Laer, Dorothee
    Skowron, Gail
    Shaw, George
    Kaur, Amitinder
    Junghans, Richard P.
    MOLECULAR THERAPY, 2017, 25 (05) : 305 - 305
  • [34] Adoptive T-cell immunotherapy for ganciclovir-resistant CMV disease after lung transplantation
    Holmes-Liew, Chien-Li
    Holmes, Mark
    Beagley, Leone
    Hopkins, Peter
    Chambers, Daniel
    Smith, Corey
    Khanna, Rajiv
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2015, 4
  • [35] Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV-specific T cells
    McGuire, Helen M.
    Rizzetto, Simone
    Withers, Barbara P.
    Clancy, Leighton E.
    Avdic, Selmir
    Stern, Lauren
    Patrick, Ellis
    Fazekas de St Groth, Barbara
    Slobedman, Barry
    Gottlieb, David J.
    Luciani, Fabio
    Blyth, Emily
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2020, 9 (07)
  • [36] Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantation
    Pei, Xu-Ying
    Liu, Xue-Fei
    Zhao, Xiang-Yu
    Lv, Meng
    Mo, Xiao-Dong
    Chang, Ying-Jun
    Shang, Qian-Nan
    Sun, Yu-Qian
    Chen, Yu-Hong
    Xu, Lan-Ping
    Wang, Yu
    Zhang, Xiao-Hui
    Liu, Kai-Yan
    Huang, Xiao-Jun
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (04) : 482 - 491
  • [37] Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantation
    Xu-Ying Pei
    Xue-Fei Liu
    Xiang-Yu Zhao
    Meng Lv
    Xiao-Dong Mo
    Ying-Jun Chang
    Qian-Nan Shang
    Yu-Qian Sun
    Yu-Hong Chen
    Lan-Ping Xu
    Yu Wang
    Xiao-Hui Zhang
    Kai-Yan Liu
    Xiao-Jun Huang
    Cellular & Molecular Immunology, 2022, 19 : 482 - 491
  • [38] Lack of CMV-specific CD4+ T-cell response after allogeneic stem cell transplantation is a risk factor for CMV organ manifestation
    Campe, H
    Gerbitz, A
    Kolb, H
    Koszinowski, U
    Jäger, G
    BONE MARROW TRANSPLANTATION, 2006, 37 : S31 - S32
  • [39] CMV-specific T-cell immunity in solid organ transplant recipients at low risk of CMV infection. Chronology and applicability in preemptive therapy
    Mena-Romo, Juan Damian
    Romero, Pilar Perez
    Martin-Gandul, Cecilia
    Gentil, Miguel Angel
    Suarez-Artacho, Gonzalo
    Lage, Ernesto
    Sanchez, Magdalena
    Cordero, Elisa
    JOURNAL OF INFECTION, 2017, 75 (04) : 336 - 345
  • [40] CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study
    Sund, Fredrik
    Lidehall, Anna-Karin
    Claesson, Kerstin
    Foss, Aksel
    Totterman, Thomas H.
    Korsgren, Olle
    Eriksson, Britt-Marie
    CLINICAL TRANSPLANTATION, 2010, 24 (03) : 401 - 409
12345